Bank of Nova Scotia Stock News

The Bank of Nova Scotia (BNS:CA) Q4 2025 Earnings Call Transcript

The Canadian bank has its sights on strong earnings growth in the coming year despite the lingering uncertainty brought on by U.S. trade policy, with capital and liquidity measures expected to remain solid.

Merck is a high-yield drug stock with a well-supported dividend payment. Enbridge is a boring energy stock with a hefty yield.

The average large U.S. bank has a yield of around 2.4%. Bank of Nova Scotia's yield is nearly twice as high at roughly 4.7%.

NEW YORK and TORONTO , Oct. 31, 2025 /PRNewswire/ - Scotiabank today announced the official launch of its modernized U.S. Cash Management program, supported by the advanced cloud-based treasury platform, ScotiaConnect®. This marks a major step in the Bank's strategy to unify and modernize cash management capabilities across the North American corridor, a US$ 1.4 trillion ( C$1.9 trillion ) annu...

Federal Realty is the only REIT to have achieved Dividend King status. Rexford Industrial is out of favor, but its business remains quite strong.

Scotiabank (BNS) is a leading Canadian multinational bank with a strong dividend history since 1833. BNS maintains a global presence through its international banking and global wealth management segments. Recent 3Q 2025 results highlight a 13% year-over-year revenue increase and a 12.2% return on equity.

This article highlights 10 high-yield dividend stocks, selected for October 2025 based on strong financial health, attractive valuations, and competitive advantages. The chosen companies, including MO, BCH, BBSEY, CVX, EPD, VZ, BNS, USB, DPSTF/DHLGY, and ARCC, offer yields above 4% and market caps over $10B. Many picks, such as VZ, MO, and EPD, provide both robust dividend income and potential ...